Viacheslav Viatchenko-Karpinski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Viacheslav Viatchenko-Karpinski has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Alina M. Golovko
University of North Dakota, Grand Forks, North Dakota, United States
1 shared publicationDonald A. Simone
University of Minnesota, Minneapolis, Minnesota, United States
1 shared publication- Han-Rong Weng
Department of Basic Sciences, California Northstate University College of Medicine, Elk Grove, CA 95757, USA
1 shared publication - Iryna A. Khasabova
Department of Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN
1 shared publication - Kalpna Gupta
Hematology/Oncology, Department of Medicine, University of California, Irvine, CA 92697, USA
1 shared publication Kathy Tang
University of Minnesota, Minneapolis, Minnesota, United States
1 shared publication
Latest Publications
- 1 April 2026
- Published by American Society of Hematology in Blood
- Vol. 148 (5) , 623-633
Chronic pain in sickle cell disease: a role for lysophosphatidic acid
Sickle cell disease (SCD) is a hereditary hemoglobinopathy characterized by persistent pain. The mechanisms underlying pain in SCD are poorly understood and opioids remain the primary treatment, despite their severe side effects. Here we investigated the contribution of lysophosphatidic acid (LPA), an endogenous pronociceptive lipid mediator, to chronic pain in SCD using humanized transgenic homozygous Berkeley mice that express >99% human sickle hemoglobin (HbSS mice) and control HbAA mice that express normal human hemoglobin A. Hyperalgesia in HbSS mice was associated with an increase in both plasma level of LPA and expression of LPAR1 mRNA in L1-L5 dorsal root ganglion (DRG). Blocking LPA synthesis with BI-2545 or blocking LPA1 receptor (LPA1R) function with siRNA or the LPA1R antagonist, AM966, reversed mechanical and heat hyperalgesia in HbSS mice. LPA also produced acute mechanical and heat hyperalgesia in HbAA mice, which resulted from the sensitization of C-fiber nociceptors. In HbSS mice, hyperalgesia was associated with sensitization of nociceptive DRG neurons. Nociceptors from hyperalgesic HbSS mice had lower rheobase, more positive resting membrane potential and higher frequency of action potential. Although no changes were found in the values of inward currents in nociceptors of HbSS mice compared to HbAA mice, outward-inactivating and non-inactivating currents were reduced, indicating the importance of potassium channels to sensitization in SCD. All these parameters were normalized by pretreatment of HbSS mice with LPA1R siRNA. Our results suggest that LPA signaling may be a promising target for treating pain in SCD.
- 1 April 2026
- Published by American Society of Hematology in Blood
- Vol. 148 (5) , 623-633
Chronic pain in sickle cell disease: a role for lysophosphatidic acid
Sickle cell disease (SCD) is a hereditary hemoglobinopathy characterized by persistent pain. The mechanisms underlying pain in SCD are poorly understood and opioids remain the primary treatment, despite their severe side effects. Here we investigated the contribution of lysophosphatidic acid (LPA), an endogenous pronociceptive lipid mediator, to chronic pain in SCD using humanized transgenic homozygous Berkeley mice that express >99% human sickle hemoglobin (HbSS mice) and control HbAA mice that express normal human hemoglobin A. Hyperalgesia in HbSS mice was associated with an increase in both plasma level of LPA and expression of LPAR1 mRNA in L1-L5 dorsal root ganglion (DRG). Blocking LPA synthesis with BI-2545 or blocking LPA1 receptor (LPA1R) function with siRNA or the LPA1R antagonist, AM966, reversed mechanical and heat hyperalgesia in HbSS mice. LPA also produced acute mechanical and heat hyperalgesia in HbAA mice, which resulted from the sensitization of C-fiber nociceptors. In HbSS mice, hyperalgesia was associated with sensitization of nociceptive DRG neurons. Nociceptors from hyperalgesic HbSS mice had lower rheobase, more positive resting membrane potential and higher frequency of action potential. Although no changes were found in the values of inward currents in nociceptors of HbSS mice compared to HbAA mice, outward-inactivating and non-inactivating currents were reduced, indicating the importance of potassium channels to sensitization in SCD. All these parameters were normalized by pretreatment of HbSS mice with LPA1R siRNA. Our results suggest that LPA signaling may be a promising target for treating pain in SCD.
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S726-S727
ENHANCED TLR7 SIGNALING ACTIVITY AUGMENTS GLUTAMATERGIC ACTIVITY AT THE FIRST NOCICEPTIVE SENSORY SYNAPSE IN THE SPINAL DORSAL HORN IN MICE WITH LUPUS-INDUCED CHRONIC PAIN
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S726-S727
Open AccessENHANCED TLR7 SIGNALING ACTIVITY AUGMENTS GLUTAMATERGIC ACTIVITY AT THE FIRST NOCICEPTIVE SENSORY SYNAPSE IN THE SPINAL DORSAL HORN IN MICE WITH LUPUS-INDUCED CHRONIC PAIN